Back
ESC Premium Access

Effect of poor glycemic control and systemic inflammation on cardiovascular outcomes in patients with coronary artery disease undergoing percutaneous coronary intervention

Session: Poster session 7 - Blood markers and reperfusion
Topic: PCI: primary PCI / patient subsets
Speaker: Doctor G. Giustino (New York, US)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Gennaro Giustino

Mount Sinai Hospital, New York (United States of America)
0 follower

19 more presentations in this session

Prognostic implications of admission anemia in patients undergoing primary percutaneous coronary intervention

Speaker: Assistant Professor D. Matic (Belgrade, RS)

Access
Abstract
Like
Thumbnail

Hydration volume and its association with short- and long-term major adverse clinical events in patients with chronic heart failure after exposure to contrast media

Speaker: Doctor H. Li (Guangzhou, CN)

Access
Abstract
Slides
Like
Thumbnail

Impact of diabetes mellitus and contrast-induced acute kidney injury on 3-year mortality in STEMI patients undergoing primary PCI

Speaker: Doctor D. Milasinovic (Belgrade, RS)

Access
Abstract
Slides
Like
Thumbnail

Higher circulating osteopontin specifically predicts cardiovascular death while urinary osteopontin predicts kidney disease progression

Speaker: Mr T. Rudholm Feldreich (Falun, SE)

Access
Abstract
Slides
Like
Thumbnail

Creatinine measurements and myocardial revascularization rates on patients with slightly elevated hs-cTnT levels

Speaker: Professor M. Vorpahl (Siegburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 7 - Blood markers and reperfusion

Speakers: Doctor G. Giustino, Assistant Professor D. Matic, Doctor H. Li, Doctor D. Milasinovic, Mr T. Rudholm Feldreich...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources